the participant be use valproate for control his/her seizure they be eligible for the study if they have not take valproate within 3 week prior to baseline visit and willing to not take it for the entire study duration valproate be an aed that partially inhibit the tca cycle via alpha-ketoglutarate dehydrogenase and should not be administer to subject take triheptanoin 